Atlas Trials

Interaction of CYP2B6 Genotype and Efavirenz With Methadone and Tizanidine PK

Clinical trial NCT05789173 · RECRUITING

Trial details

NCT number
NCT05789173
Sponsor
Indiana University
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Drug-Drug Interaction
Start date
2023-10-06
Primary completion
2027-05-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.